Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 86

1.

TNF-Alpha in the Locomotor System beyond Joints: High Degree of Involvement in Myositis in a Rabbit Model.

Forsgren S, Renström L, Purdam C, Gaida JE.

Int J Rheumatol. 2012;2012:637452. doi: 10.1155/2012/637452. Epub 2012 Mar 7.

2.

Bilateral increase in expression and concentration of tachykinin in a unilateral rabbit muscle overuse model that leads to myositis.

Song Y, Stål PS, Yu JG, Forsgren S.

BMC Musculoskelet Disord. 2013 Apr 12;14:134. doi: 10.1186/1471-2474-14-134.

3.

Marked Effects of Tachykinin in Myositis Both in the Experimental Side and Contralaterally: Studies on NK-1 Receptor Expressions in an Animal Model.

Song Y, Stål PS, Yu J, Forsgren S.

ISRN Inflamm. 2013 Jan 29;2013:907821. doi: 10.1155/2013/907821. eCollection 2013.

4.
5.

Enhanced expression of tumor necrosis factor receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints.

Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Feldmann M.

Eur J Immunol. 1992 Jul;22(7):1907-12.

PMID:
1320571
6.

Immunolocalization of tumor necrosis factor-alpha and its receptors in inflammatory myopathies.

De Bleecker JL, Meire VI, Declercq W, Van Aken EH.

Neuromuscul Disord. 1999 Jun;9(4):239-46.

PMID:
10399751
8.

The role of cytokines in osteoarthritis pathophysiology.

Fernandes JC, Martel-Pelletier J, Pelletier JP.

Biorheology. 2002;39(1-2):237-46. Review.

PMID:
12082286
9.

Analysis of IL-1 and TNF-alpha gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization.

MacNaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ.

J Immunol. 1990 Dec 15;145(12):4154-66.

PMID:
2258613
10.

Immunohistochemical study of skeletal muscle in rheumatoid myositis.

Ancuţa C, Ancuţa E, Iordache C, Ceauşu M, Chirieac R.

Rom J Morphol Embryol. 2009;50(2):223-7.

11.

Choline acetyltransferase and the nicotinic acetylcholine receptor AChRα7 in experimental myositis.

Spang C, Forsgren S.

Int Immunopharmacol. 2015 Nov;29(1):189-94. doi: 10.1016/j.intimp.2015.05.053. Epub 2015 Jun 15.

PMID:
26086364
14.

Comparison of cathepsins K and S expression within the rheumatoid and osteoarthritic synovium.

Hou WS, Li W, Keyszer G, Weber E, Levy R, Klein MJ, Gravallese EM, Goldring SR, Brömme D.

Arthritis Rheum. 2002 Mar;46(3):663-74.

15.

Possible pathogenic mechanisms in inflammatory myopathies.

Lundberg IE, Dastmalchi M.

Rheum Dis Clin North Am. 2002 Nov;28(4):799-822. Review.

PMID:
12506773
16.

Cytokines in idiopathic inflammatory myopathies.

Salomonsson S, Lundberg IE.

Autoimmunity. 2006 May;39(3):177-90. Review.

PMID:
16769651
17.

Local treatment with the selective IkappaB kinase beta inhibitor NEMO-binding domain peptide ameliorates synovial inflammation.

Tas SW, Vervoordeldonk MJ, Hajji N, May MJ, Ghosh S, Tak PP.

Arthritis Res Ther. 2006;8(4):R86.

19.

Interleukin (IL)-23 p19 expression induced by IL-1beta in human fibroblast-like synoviocytes with rheumatoid arthritis via active nuclear factor-kappaB and AP-1 dependent pathway.

Liu FL, Chen CH, Chu SJ, Chen JH, Lai JH, Sytwu HK, Chang DM.

Rheumatology (Oxford). 2007 Aug;46(8):1266-73. Epub 2007 Jun 14.

20.

Synovial localization of tumor necrosis factor in patients with rheumatoid arthritis.

Husby G, Williams RC Jr.

J Autoimmun. 1988 Aug;1(4):363-71.

PMID:
3075463
Items per page

Supplemental Content

Write to the Help Desk